Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuronostatin - a Glucagonotropic Agent in Humans?

NCT06143267 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.

NCT NCT06143267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06143267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuronostatin - a Glucagonotropic Agent in Humans?
Lead sponsor
University Hospital, Gentofte, Copenhagen
Phase
Not applicable
Overall status
Completed
Start date
December 6, 2022
Completion date
September 25, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoglycemia, type 1 diabetes, type1diabetes